1073477-73-2

Basic information

• Product Name: 2-(2-fluoro-4-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• Synonyms: 2-(2-fluoro-4-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• CAS NO: 1073477-73-2
• Molecular Weight: 306.065
• Mol File: 1073477-73-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2-(2-fluoro-4-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-fluoro-4-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(1073477-73-2)
• EPA Substance Registry System: 2-(2-fluoro-4-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(1073477-73-2)

Safety Data

• Hazardous Substances Data: 1073477-73-2(Hazardous Substances Data)

Upstream product

• 123572-58-7 2-fluoro-4-(trifluoromethoxy)aniline 
• 1077-01-6 meta-fluoro(trifluoromethoxy)benzene 
• 123572-64-5 2-fluoro-1-nitro-4-(trifluoromethoxy) benzene 
• 168971-68-4 1-bromo-2-fluoro-4-(trifluoromethoxy)benzene 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1073477-74-3 2-fluoro-4-(trifluoromethoxy) phenol 
• 1251843-86-3 Methyl 2-(2-fluoro-4-(trifluoromethoxy)phenyl)isonicotinate 

Relevant articles and documents

6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

A 6-oxo-1,6-dihydropyridazine derivative, a preparation method therefor and medical use thereof, in particular, a 6-oxo-1,6-dihydropyridazine derivative represented by general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, and use thereof as a NaV inhibitor and use thereof in the preparation of a drug for the treatment and/or prevention of pain and pain-related diseases. Each substituent in general formula (I) is the same as defined in the description.

METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES

The instant invention describes compounds of Formula I having metalloenzyme modulating activity, and methods of treating diseases disorders or symptoms thereof mediated by such metalloenzymes.

PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of G protein-coupled receptor 119 ("GPR119") in a patient.